Shareholders' Equity | 4. a. Authorized ● Unlimited number of common shares without par value. ● Unlimited number of first preferred shares without par value. ● Unlimited number of second preferred shares without par value. b. Share based compensation Share based compensation was recognized in the unaudited condensed consolidated statements of operations for the three months ended March 31, 2023 and 2022 as follows: Three months ended March 31, 2023 2022 Exploration $ 372,687 $ 235,683 Corporate salaries and benefits 246,970 174,385 Directors’ fees 221,170 266,181 Total $ 840,827 $ 676,249 Share purchase options A summary of share purchase option activity within the Company’s share-based compensation plan (the “Plan”) for the year ended December 31, 2022 and three months ended March 31, 2023 is as follows: Number of Weighted Average Options Exercise Price (C$) Balance December 31, 2021 2,497,150 $ 9.15 Options expired (305,000) 8.71 Options cancelled or forfeited (246,500) 9.11 Balance December 31, 2022 1,945,650 $ 9.23 Options exercised (12,500) 4.40 Options cancelled or forfeited (6,000) 9.93 Options expired (148,900) 6.19 Balance March 31, 2023 1,778,250 $ 9.52 During the three months ended March 31, 2023 and 2022, the Company’s total share based compensation from options was $80,320 (2022: $252,900), respectively. No options were granted during the three months ended March 31, 2023 nor 2022. During the three months ended March 31, 2023, the intrinsic value of share purchase options exercised was $12,470. An analysis of outstanding share purchase options as of March 31, 2023 is as follows: Options Outstanding Options Exercisable Range of Exercise Remaining Remaining Prices (C$) Number Price (C$) 1 Life 2 Number Price (C$) 1 Life 2 $3.50 - $6.02 57,500 3.70 1.98 45,000 3.50 1.97 $6.03 - 11.80 1,720,750 9.71 2.07 1,425,500 9.47 1.91 $3.50 - $11.80 1,778,250 9.52 2.07 1,470,500 9.29 1.91 1 2 As of March 31, 2023, all unvested options are expected to vest and unvested compensation of $246,443 will be recognized. The weighted average remaining amortization period of vested options is 0.75 years. As of March 31, 2023, the intrinsic value of outstanding and exercisable share purchase options is $98,834 and $83,859, respectively. Restricted Share Units The following table summarizes activity for restricted share units (“RSUs”) awarded under the Plan that vest over the required service period of the participant. Weighted Average Share Grant Date Units Fair Value Unvested, December 31, 2021 42,334 $ 5.66 Granted 370,098 4.04 Distributed (vested) (36,168) 5.00 Cancelled (4,308) 4.03 Unvested, December 31, 2022 371,956 $ 4.13 Granted 370,039 3.42 Distributed (vested) (108,006) 4.02 Cancelled (4,453) 3.77 Unvested, March 31, 2023 629,536 $ 3.73 During the three months ended March 31, 2023, the Company awarded 370,039 RSUs (2022: 330,098 RSUs), with a weighted average grant date fair value of $3.42 per RSU (2022: $4.03), or approximately $1.3 million in total (2022: $1.3 million). During the three months ended March 31, 2023 and 2022, the Company has recognized $299,628 and $110,740, respectively, in compensation expense related to RSUs and expects to record an additional $1.7 million in compensation expense over the next 1.74 years. The unvested units of March 31, 2023 are scheduled to vest as follows: Remainder of 2023 38,618 2024 239,540 2025 228,660 2026 122,718 Total 629,536 Unvested units will be forfeited by participants upon termination of employment in advance of vesting, with the exception of termination due to retirement if certain criteria are met. Performance Share Units The following table summarizes activity for performance share units (“PSUs”) and market-based performance share units (“MPSUs”) awarded under the Plan: Weighted Average Share Grant Date Units Fair Value Unvested, December 31, 2021 10,750 $ 5.66 Granted 267,451 6.73 Distributed (3,750) 3.42 Cancelled (11,185) 5.83 Unvested, December 31, 2022 263,266 $ 6.77 Granted 277,535 5.98 Distributed (7,250) 2.02 Cancelled (1,619) 6.60 Unvested, March 31, 2023 531,932 $ 6.42 During the three months ended March 31, 2023 and 2022, the Company has recognized $220,558 and $55,666, respectively, in compensation expense related to PSUs and MPSUs and expects to record an additional $2.7 million in compensation expense over the next 2.53 years. The unvested units of March 31, 2023 are scheduled to vest as follows: Remainder of 2023 7,500 2024 — 2025 247,524 2026 276,908 Total 531,932 PSUs Market-based PSUs During the three months ended March 31, 2023, the Company awarded 277,535 MPSUs (2022: 249,951 MPSUs) that had a weighted grant date fair value of $5.98 (2022: $6.99) per MPSU or approximately $1.65 million (2022: $1.75 million) in total. The grant date fair value of MPSUs was estimated using a Monte Carlo simulation model. Assumptions and estimates utilized in the model include expected volatilities of the Corporation’s share price and the GDXJ Index, the Company’s risk-free interest rate and expected dividends. The probabilities of the actual number of MPSUs expected to vest and resultant actual number of shares of common stock expected to be awarded are reflected in the grant date fair values of the various MPSU awards. The per MPSU grant date fair value for the market condition was based on the following variables: 2023 2022 Grant date fair value $ 5.98 $ 6.99 Risk-free interest rate 4.15 % 1.61 % Expected term (in years) 3.0 3.0 Expected share price volatility 65.74 % 63.35 % Expected dividend yield — — The expected volatility utilized is based on the historical volatilities of the Corporation’s common stock and the GDXJ Index in order to model the stock price movements. The volatility used was calculated over the most recent three year period. The risk-free interest rates used are based on the implied yield available on a U.S. Treasury zero-coupon bill with a term equivalent to the Performance Period. The expected dividend yield of zero was used since it is the mathematical equivalent to reinvesting dividends in each issuing entity over the Performance Period. Deferred Share Units The following table summarizes activity for deferred share units (“DSUs”) awarded under the Plan: Weighted Average Share Grant Date Units Fair Value Outstanding, December 31, 2021 29,213 $ 5.39 Granted 116,462 3.42 Outstanding, December 31, 2022 145,675 3.82 Granted 67,075 3.58 Outstanding, March 31, 2023 212,750 3.75 Under the Plan, the Company may issue DSUs to non-employee directors. During the three months ended March 31, 2023 and 2022, 67,075 and 62,669 shares, respectively with a fair value of $240,321 and $256,943 were granted to the non-employee directors and the related compensation expense was charged to directors’ fees in the unaudited condensed consolidated statements of operations. c. Warrants There was a total of 200,000 warrants outstanding as of March 31, 2023 that expire on May 9, 2023. |